Literature DB >> 21384657

[Reliability of a less-invasive cardiac output monitor in the perioperative period of a patient with severe dilated cardiomyopathy].

Yohei Sotomi1, Chie Nishiyama, Tomoaki Shimizu, Takashi Kita, Naritoshi Maki, Shigeta Sasaki.   

Abstract

Recently, various less-invasive cardiac output monitors are used for a variety of cases. We used FloTrac system for a patient with severe dilated cardiomyopathy (LVDd/Ds = 75/62 mm, EF = 22%) and recognized its limitation. A 52-year-old woman underwent left partial mastectomy. There were no significant events during the operation. In the ICU, she developed symptoms of low output state, but we could not detect any significant changes on Vigileo Monitor. Arterial pressure-based cardiac output (APCO) measurement with FloTrac is based on the patient's characteristics, blood pressure waveform and basic data stored in Vigileo Monitor. Its accuracy is worse with arterial wave artifact, compromise of the arterial catheter, aortic regurgitation, intense peripheral vasoconstriction, irregular pulse and severe cardiac hypofunction. Thus, its reliability is influenced by various conditions, especially in critically ill patients. FloTrac system is very useful for the management of cardiocirculatory dynamics, but we should be familiar with its limitations.

Entities:  

Mesh:

Year:  2011        PMID: 21384657

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Applications of minimally invasive cardiac output monitors.

Authors:  Jahan Porhomayon; Gino Zadeii; Samuel Congello; Nader D Nader
Journal:  Int J Emerg Med       Date:  2012-04-24

2.  The impact of systemic vascular resistance on the accuracy of the FloTrac/Vigileo™ system in the perioperative period of cardiac surgery: a prospective observational comparison study.

Authors:  Yohei Sotomi; Katsuomi Iwakura; Yoshiharu Higuchi; Kazuo Abe; Junko Yoshida; Takafumi Masai; Kenshi Fujii
Journal:  J Clin Monit Comput       Date:  2013-06-08       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.